> top > docs > PubMed:33174592 > annotations

PubMed:33174592 JSON TXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id	Subject	Object	Predicate	Lexical cue	fma_id
T1	19-35	Body_part	denotes	immunoglobulin G	http://purl.org/sig/ont/fma/fma62872
T2	456-469	Body_part	denotes	immune system	http://purl.org/sig/ont/fma/fma9825
T3	521-524	Body_part	denotes	IgG	http://purl.org/sig/ont/fma/fma62872
T4	674-677	Body_part	denotes	IgG	http://purl.org/sig/ont/fma/fma62872
T5	894-897	Body_part	denotes	IgG	http://purl.org/sig/ont/fma/fma62872
T6	967-986	Body_part	denotes	N-acetylglucosamine	http://purl.org/sig/ont/fma/fma82787
T7	1039-1042	Body_part	denotes	IgG	http://purl.org/sig/ont/fma/fma62872

LitCovid-PD-UBERON

Id	Subject	Object	Predicate	Lexical cue	uberon_id
T1	456-469	Body_part	denotes	immune system	http://purl.obolibrary.org/obo/UBERON_0002405

LitCovid-PD-MONDO

Id	Subject	Object	Predicate	Lexical cue	mondo_id
T1	76-84	Disease	denotes	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096
T2	176-184	Disease	denotes	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096
T3	254-262	Disease	denotes	SARS-CoV	http://purl.obolibrary.org/obo/MONDO_0005091
T4	504-512	Disease	denotes	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096
T5	721-729	Disease	denotes	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id	Subject	Object	Predicate	Lexical cue
T1	86-87	http://purl.obolibrary.org/obo/CLO_0001020	denotes	A
T2	215-216	http://purl.obolibrary.org/obo/CLO_0001020	denotes	a
T3	456-469	http://purl.obolibrary.org/obo/UBERON_0002405	denotes	immune system
T4	487-488	http://purl.obolibrary.org/obo/CLO_0001020	denotes	a
T5	1208-1215	http://purl.obolibrary.org/obo/UBERON_0000473	denotes	testing

LitCovid-PD-CHEBI

Id	Subject	Object	Predicate	Lexical cue	chebi_id
T1	967-986	Chemical	denotes	N-acetylglucosamine	http://purl.obolibrary.org/obo/CHEBI_28009\|http://purl.obolibrary.org/obo/CHEBI_59640
T3	988-994	Chemical	denotes	GlcNAc	http://purl.obolibrary.org/obo/CHEBI_506227\|http://purl.obolibrary.org/obo/CHEBI_73685

LitCovid-PD-GO-BP

Id	Subject	Object	Predicate	Lexical cue
T1	525-538	http://purl.obolibrary.org/obo/GO_0070085	denotes	glycosylation
T2	570-580	http://purl.obolibrary.org/obo/GO_0065007	denotes	regulation

LitCovid-sentences

Id	Subject	Object	Predicate	Lexical cue
T1	0-85	Sentence	denotes	Composition of the immunoglobulin G glycome associates with the severity of COVID-19.
T2	86-195	Sentence	denotes	A large variation in the severity of disease symptoms is one of the key open questions in COVID-19 pandemics.
T3	196-427	Sentence	denotes	The fact that only a small subset of people infected with SARS-CoV-2 develop severe disease suggests that there have to be some predisposing factors, but biomarkers that reliably predict disease severity have not been found so far.
T4	428-730	Sentence	denotes	Since overactivation of the immune system is implicated in a severe form of COVID-19 and the IgG glycosylation is known to be involved in the regulation of different immune processes, we evaluated the association of inter-individual variation in IgG N-glycome composition with the severity of COVID-19.
T5	731-908	Sentence	denotes	The analysis of 166 severe and 167 mild cases from hospitals in Spain, Italy and Portugal revealed statistically significant differences in the composition of the IgG N-glycome.
T6	909-1038	Sentence	denotes	The most notable difference was the decrease in bisecting N-acetylglucosamine (GlcNAc) in severe patients from all three cohorts.
T7	1039-1216	Sentence	denotes	IgG galactosylation was also lower in severe cases in all cohorts, but the difference in galactosylation was not statistically significant after correction for multiple testing.

GlyCosmos6-Glycan-Motif-Image

Id	Subject	Object	Predicate	Lexical cue	image
T1	967-986	Glycan_Motif	denotes	N-acetylglucosamine	https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G64581RP

sentences

Id	Subject	Object	Predicate	Lexical cue
T1	0-85	Sentence	denotes	Composition of the immunoglobulin G glycome associates with the severity of COVID-19.
T2	86-195	Sentence	denotes	A large variation in the severity of disease symptoms is one of the key open questions in COVID-19 pandemics.
T3	196-427	Sentence	denotes	The fact that only a small subset of people infected with SARS-CoV-2 develop severe disease suggests that there have to be some predisposing factors, but biomarkers that reliably predict disease severity have not been found so far.
T4	428-730	Sentence	denotes	Since overactivation of the immune system is implicated in a severe form of COVID-19 and the IgG glycosylation is known to be involved in the regulation of different immune processes, we evaluated the association of inter-individual variation in IgG N-glycome composition with the severity of COVID-19.
T5	731-908	Sentence	denotes	The analysis of 166 severe and 167 mild cases from hospitals in Spain, Italy and Portugal revealed statistically significant differences in the composition of the IgG N-glycome.
T6	909-1038	Sentence	denotes	The most notable difference was the decrease in bisecting N-acetylglucosamine (GlcNAc) in severe patients from all three cohorts.
T7	1039-1216	Sentence	denotes	IgG galactosylation was also lower in severe cases in all cohorts, but the difference in galactosylation was not statistically significant after correction for multiple testing.
T1	0-85	Sentence	denotes	Composition of the immunoglobulin G glycome associates with the severity of COVID-19.
T2	86-195	Sentence	denotes	A large variation in the severity of disease symptoms is one of the key open questions in COVID-19 pandemics.
T3	196-427	Sentence	denotes	The fact that only a small subset of people infected with SARS-CoV-2 develop severe disease suggests that there have to be some predisposing factors, but biomarkers that reliably predict disease severity have not been found so far.
T4	428-730	Sentence	denotes	Since overactivation of the immune system is implicated in a severe form of COVID-19 and the IgG glycosylation is known to be involved in the regulation of different immune processes, we evaluated the association of inter-individual variation in IgG N-glycome composition with the severity of COVID-19.
T5	731-908	Sentence	denotes	The analysis of 166 severe and 167 mild cases from hospitals in Spain, Italy and Portugal revealed statistically significant differences in the composition of the IgG N-glycome.
T6	909-1038	Sentence	denotes	The most notable difference was the decrease in bisecting N-acetylglucosamine (GlcNAc) in severe patients from all three cohorts.
T7	1039-1216	Sentence	denotes	IgG galactosylation was also lower in severe cases in all cohorts, but the difference in galactosylation was not statistically significant after correction for multiple testing.

GlyCosmos6-Glycan-Motif-Structure

Id	Subject	Object	Predicate	Lexical cue
T1	967-986	https://glytoucan.org/Structures/Glycans/G64581RP	denotes	N-acetylglucosamine

mondo_disease

Id	Subject	Object	Predicate	Lexical cue	mondo_id
T1	76-84	Disease	denotes	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096
T2	176-184	Disease	denotes	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096
T3	254-264	Disease	denotes	SARS-CoV-2	http://purl.obolibrary.org/obo/MONDO_0100096
T4	504-512	Disease	denotes	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096
T5	721-729	Disease	denotes	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096

NCBITAXON

Id	Subject	Object	Predicate	Lexical cue	db_id
T1	254-262	OrganismTaxon	denotes	SARS-CoV	694009

Anatomy-UBERON

Id	Subject	Object	Predicate	Lexical cue	uberon_id
T1	456-469	Body_part	denotes	immune system	http://purl.obolibrary.org/obo/UBERON_0002405